About US
Contact us
-
Supreme Court rules in favor of ‘pharma’ data miningBy Ananya Mandal, MD The U.S. Supreme Court ruled that the pharmaceutical companies could use the information that they gained from doctors’ prescribing records. The data mining had been restricted2011/6/30
-
Drug labels sometimes lack key safety warnings: Consumer Reports HealthNo Federal Monitoring of Drug Labels; What Consumers Can Do to Stay Safe It's comparable to driving a car without a seatbelt—a new investigation from Consumer Reports Health finds that drug labels2011/6/29
-
Merck, UPS extend logistics and distribution agreementUPS (NYSE: UPS) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the companies have significantly broadened their existing distribution and logistics agree2011/6/29
-
Study proves efficacy of cellulose powder, without any adverse effects, in treatment of hay fever for childrenA cellulose powder has been used increasingly for many years against allergic rhinitis. Still, there has been a shortage of scientific evidence for its efficacy in seasonal allergic rhinitis (hay feve2011/6/29
-
SFDA issues the No.149 announcement of drug administrative protectionThe State Food and Drug Administration (SFDA) issued the No.149 Drug Administrative Protection Announcement on June 23, 2011, declaring the revocation of drug administrative protection for Ortho-McNei2011/6/28
-
Drug shortages have tripled during the last six yearsThe Baltimore Sun: Many Drugs In Short Supply At Hospitals, Pharmacies The drugs are among hundreds that have been in short supply at the nation's hospitals, and more recently, community pharmacies.2011/6/28
-
Endo recalls two lots of Endocet TabletsEndo Pharmaceuticals (Nasdaq: ENDP) today issued a voluntary nationwide consumer level recall of Endocet® (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70,2011/6/28
-
GlaxoSmithKline to Pay Settlement over Substandard Manufacturing ProcessesGlaxoSmithKline has agreed to pay $40.75m to 37 states and the District of Columbia in a settlement over substandard drug manufacturing processes. The settlement, announced by the company and Attor2011/6/27
-
Supreme Court sides with drug makers in two decisionsOne would shield pharmaceutical companies from most lawsuits filed by people injured by taking generic drugs. The other strikes down a Vermont law that banned some commercial uses — "data mining" — of2011/6/27
-
SFDA Deputy Commissioner Wu Zhen meets Director-General of Public Health of the Netherlands Ministry of Health, Welfare and SportOn June 21, 2011, Wu Zhen, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Paul Huijts, Director-General of Public Health of the Ministry of Health, Welfare2011/6/24